Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 23430122)

1.

Approval of a tuberculosis drug based on a paradoxical surrogate measure.

Avorn J.

JAMA. 2013 Apr 3;309(13):1349-50. doi: 10.1001/jama.2013.623. No abstract available.

PMID:
23430122
2.

MDR-TB has new drug foe after fast-track approval.

Voelker R.

JAMA. 2013 Feb 6;309(5):430. doi: 10.1001/jama.2013.94. No abstract available.

PMID:
23385248
3.

Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.

[No authors listed]

Med Lett Drugs Ther. 2013 Aug 19;55(1423):66-8. No abstract available.

PMID:
23959388
4.

Infectious disease. Approval of novel TB drug celebrated--with restraint.

Cohen J.

Science. 2013 Jan 11;339(6116):130. doi: 10.1126/science.339.6116.130. No abstract available.

PMID:
23307714
5.

Race heats up for first-to-market drugs for resistant tuberculosis.

Willyard C.

Nat Med. 2012 Aug;18(8):1157. doi: 10.1038/nm0812-1157. No abstract available.

PMID:
22869168
6.

Unorthodox approach to the development of a new antituberculosis therapy.

Barry CE 3rd.

N Engl J Med. 2009 Jun 4;360(23):2466-7. doi: 10.1056/NEJMe0903012. No abstract available.

7.

Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.

Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2013 Oct 25;62(RR-09):1-12. Erratum in: MMWR Recomm Rep. 2013 Nov 15;62(45):906.

8.

FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Cox E, Laessig K.

N Engl J Med. 2014 Aug 21;371(8):689-91. doi: 10.1056/NEJMp1314385. No abstract available.

9.

Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis.

Deoghare S.

Indian J Pharmacol. 2013 Sep-Oct;45(5):536-7. doi: 10.4103/0253-7613.117765. No abstract available.

10.

Multidrug-resistant tuberculosis and bedaquiline.

Salfinger M, Somoskövi A.

N Engl J Med. 2014 Dec 18;371(25):2435-6. doi: 10.1056/NEJMc1412235#SA1. No abstract available.

PMID:
25517715
11.

Multidrug-resistant tuberculosis and bedaquiline.

Diacon AH, Lounis N, Dannemann B.

N Engl J Med. 2014 Dec 18;371(25):2436. doi: 10.1056/NEJMc1412235. No abstract available.

12.

Public-private partnership tackles TB challenges in parallel.

Webb S.

Nat Rev Drug Discov. 2009 Aug;8(8):599-600. doi: 10.1038/nrd2955.

PMID:
19644463
13.

The diarylquinoline TMC207 for multidrug-resistant tuberculosis.

Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, Pistorius C, Krause R, Bogoshi M, Churchyard G, Venter A, Allen J, Palomino JC, De Marez T, van Heeswijk RP, Lounis N, Meyvisch P, Verbeeck J, Parys W, de Beule K, Andries K, Mc Neeley DF.

N Engl J Med. 2009 Jun 4;360(23):2397-405. doi: 10.1056/NEJMoa0808427.

14.

Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.

Jiang RH, Xu HB, Li L.

Int J Antimicrob Agents. 2013 Jul;42(1):36-41. doi: 10.1016/j.ijantimicag.2013.02.019. Epub 2013 Apr 11.

PMID:
23582696
15.

A review of tuberculosis: Focus on bedaquiline.

Chan B, Khadem TM, Brown J.

Am J Health Syst Pharm. 2013 Nov 15;70(22):1984-94. doi: 10.2146/ajhp130199. Review.

PMID:
24173008
16.

New tuberculosis drug development. How can we do better?

O'Brien RJ, Vernon AA.

Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1705-7. No abstract available.

PMID:
9620895
17.

Delamanid for multidrug-resistant pulmonary tuberculosis.

Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park SK, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh WJ, Seaworth B, Geiter LJ, Wells CD.

N Engl J Med. 2012 Jun 7;366(23):2151-60. doi: 10.1056/NEJMoa1112433.

18.

Moxifloxacin versus ethambutol in initial tuberculosis treatment.

Sellier P, Delcey V, Raskine L, Sanson-Le-Pors MJ, Bergmann JF.

Lancet. 2009 Jun 27;373(9682):2198; author reply 2198-9. doi: 10.1016/S0140-6736(09)61189-2. No abstract available.

PMID:
19560598
19.

TMC207 becomes bedaquiline, a new anti-TB drug.

Palomino JC, Martin A.

Future Microbiol. 2013 Sep;8(9):1071-80. doi: 10.2217/fmb.13.85. Review.

PMID:
24020736
20.

Tuberculosis success.

Jones D.

Nat Rev Drug Discov. 2013 Mar;12(3):175-6. doi: 10.1038/nrd3957. No abstract available.

PMID:
23449293
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk